Bicycle Therapeutics PLC
NASDAQ:BCYC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.81
27.51
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
BCYC Price Targets Summary
Bicycle Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for BCYC is 38.76 USD with a low forecast of 25.25 USD and a high forecast of 57.75 USD.
BCYC Last Price Targets
Bicycle Therapeutics PLC
The latest public price target was made on Oct 24, 2024 by Jay Olson from Oppenheimer , who expects BCYC stock to rise by 227% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Jay Olson
Oppenheimer
|
48
USD
Upside 227% |
1 month ago
Oct 24, 2024
|
Oppenheimer Reiterates Outperform Rating on Bicycle Therapeutics (BCYC)
StreetInsider
|
Kalpit Patel
B.Riley Financial
|
28
USD
Upside 91% |
1 month ago
Oct 24, 2024
|
B.Riley Reiterates Neutral Rating on Bicycle Therapeutics (BCYC)
StreetInsider
|
Swayampakula Ramakanth
H.C. Wainwright
|
55
USD
Upside 275% |
3 months ago
Sep 16, 2024
|
H.C. Wainwright Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BCYC's stock price target?
Price Target
38.76
USD
According to Wall Street analysts, the average 1-year price target for BCYC is 38.76 USD with a low forecast of 25.25 USD and a high forecast of 57.75 USD.
What is Bicycle Therapeutics PLC's Revenue forecast?
Projected CAGR
52%
For the last 6 years the compound annual growth rate for Bicycle Therapeutics PLC's revenue is 54%. The projected CAGR for the next 4 years is 52%.